Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy
Patients with myotonic dystrophy type 1 (DM1) identify chronic fatigue as the most debilitating symptom, which manifests in part as prolonged recovery after exercise. Clinical features of DM1 result from pathogenic gain-of-function activity of transcripts containing an expanded microsatellite CUG re...
Saved in:
Main Authors: | Ningyan Hu (Author), Eunjoo Kim (Author), Layal Antoury (Author), Jia Li (Author), Paloma González-Pérez (Author), Seward B. Rutkove (Author), Thurman M. Wheeler (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
by: Dominic Jauvin, et al.
Published: (2017) -
Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
by: Anchel González-Barriga, et al.
Published: (2013) -
Congenital Myotonic Dystrophy
by: J Gordon Millichap
Published: (1987) -
Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice
by: Mingxing Wang, et al.
Published: (2018) -
Respiratory Management of Myotonic Dystrophy
by: John R Bach, et al.
Published: (2020)